As of 2025-12-18, the Relative Valuation of C4 Therapeutics Inc (CCCC) is (29.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.05 USD, the upside of C4 Therapeutics Inc based on Relative Valuation is -1531.1%.
The range of the Relative Valuation is (21.38) - (30.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 25.1x | 21.2x |
| Forward P/E multiples | 17.4x - 35.8x | 26.6x |
| Fair Price | (21.38) - (30.84) | (29.34) |
| Upside | -1143.0% - -1604.5% | -1531.1% |
| Date | P/E |
| 2025-12-15 | -1.98 |
| 2025-12-12 | -2.01 |
| 2025-12-11 | -2.07 |
| 2025-12-10 | -2.10 |
| 2025-12-09 | -2.11 |
| 2025-12-08 | -2.07 |
| 2025-12-05 | -2.17 |
| 2025-12-04 | -2.11 |
| 2025-12-03 | -2.29 |
| 2025-12-02 | -1.98 |
| 2025-12-01 | -2.07 |
| 2025-11-28 | -2.21 |
| 2025-11-26 | -2.18 |
| 2025-11-25 | -2.02 |
| 2025-11-24 | -2.00 |
| 2025-11-21 | -1.99 |
| 2025-11-20 | -1.94 |
| 2025-11-19 | -2.03 |
| 2025-11-18 | -2.02 |
| 2025-11-17 | -2.03 |
| 2025-11-14 | -2.01 |
| 2025-11-13 | -1.99 |
| 2025-11-12 | -2.02 |
| 2025-11-11 | -2.02 |
| 2025-11-10 | -1.90 |
| 2025-11-07 | -1.90 |
| 2025-11-06 | -1.94 |
| 2025-11-05 | -1.93 |
| 2025-11-04 | -1.84 |
| 2025-11-03 | -2.02 |
| 2025-10-31 | -2.12 |
| 2025-10-30 | -2.00 |
| 2025-10-29 | -2.04 |
| 2025-10-28 | -2.10 |
| 2025-10-27 | -2.16 |
| 2025-10-24 | -1.99 |
| 2025-10-23 | -1.94 |
| 2025-10-22 | -1.86 |
| 2025-10-21 | -2.00 |
| 2025-10-20 | -2.07 |
| 2025-10-17 | -1.93 |
| 2025-10-16 | -2.02 |
| 2025-10-15 | -1.81 |
| 2025-10-14 | -1.64 |
| 2025-10-13 | -1.72 |
| 2025-10-10 | -1.83 |
| 2025-10-09 | -1.96 |
| 2025-10-08 | -1.81 |
| 2025-10-07 | -1.84 |
| 2025-10-06 | -1.86 |